Therapy News and Research

RSS

Study highlights the impact of gambling on partners and families

With the lure of online gambling high during COVID-19 lockdowns - and some gambling venues now reopening - partners and families of problem gamblers may be the first to see a problem emerging.

22 Jul 2020

Researchers investigate the genetic and molecular basis of PD-L2 regulation

In immune-related disorders, therapy often involves identifying the molecules responsible for immune dysregulation and targeting them using drugs.

22 Jul 2020

ESC Congress 2020 to host the biggest online gathering of cardiovascular professionals

The world's largest cardiovascular meeting - ESC Congress 2020 - is set to host the biggest online gathering of cardiovascular professionals the world has ever seen.

22 Jul 2020

Researchers identify potential new combination therapy to treat head and neck cancer

Researchers at the UCLA Jonsson Comprehensive Cancer Center and UCLA School of Dentistry have identified a potential new combination therapy to treat advanced head and neck squamous cell carcinoma, the most common type of head and neck cancer.

21 Jul 2020

Fusion protein may help treat pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is an insidious disease. Symptoms may begin slowly, and even before they appear, extensive damage has caused the obstruction of small arteries leading to increased blood pressure in the lungs.

21 Jul 2020

Research suggests a possible new approach to treating neurodegenerative diseases

Researchers at Vanderbilt University Medical Center have shown for the first time that when one optic nerve in the eye is damaged, as in glaucoma, the opposite optic nerve comes to the rescue by sharing its metabolic energy.

21 Jul 2020

Fasting-mimicking diet along with hormone therapy could help treat breast cancer

A USC-led team of scientists has found that a fasting-mimicking diet combined with hormone therapy has the potential to help treat breast cancer, according to newly published animal studies and small clinical trials in humans.

21 Jul 2020

Mindfulness training helps reduce intimate partner violent behavior in men

The last few months have been particularly difficult for people living in a violent relationship.

21 Jul 2020

Analysis: Mental health crisis will lead to a surge in referrals for NHS’ talking therapy service

A mental health crisis on an ‘unprecedented’ scale will lead to a surge in referrals to the NHS’ talking therapy service.

21 Jul 2020

Drug discovery pipeline to exploit transcription factors for cancer therapy

Cancer is a leading cause of death and one of the most complex challenges to modern medicine. By employing cutting-edge technologies that precisely measure the effects of candidate targets and drugs on the fundamental process of transcription, the new start-up company QUANTRO Therapeutics strives to radically change the precision and scope of cell-based drug screening.

21 Jul 2020

Ten major risk factors for Alzheimer's disease

Researchers have collated available scientific evidence on risk factors associated with Alzheimer's disease and come up with a list of ten important ones.

21 Jul 2020

Researchers visualize DNA G-quadruplex formation in live cells for the first time

The formation of four-stranded DNA has been tracked in living human cells, allowing scientists to see how it works, and its possible role in cancer.

20 Jul 2020

Age-related hearing loss mainly caused by damage to hair cells, study shows

In a new study of human ear tissues, hearing scientists have demonstrated that age-related hearing loss, also called presbycusis, is mainly caused by damage to hair cells, the sensory cells in the inner ear that transform sound-induced vibrations into the electrical signals that are relayed to the brain by the auditory nerve.

20 Jul 2020

New assay improves detection of SARS-CoV-2 antibodies

Researchers at the University of California Santa Cruz have developed a new assay for the detection of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that they say provides significant advantages over the techniques currently used.

20 Jul 2020

Experimental therapy slows zika replication and prevents microcephaly in mice

An international group of researchers have discovered that inhibiting AHR (aryl hydrocarbon receptor), a protein with roles in regulating immunity, stem cell maintenance and cellular differentiation, enables the immune system to combat replication of zika virus in the organism far more effectively.

20 Jul 2020

Josep Carreras Institute's spin-off aims to develop new immuno-oncological therapeutic tools

The Josep Carreras Leukaemia Research Institute, a public centre pertaining to the Generalitat de Catalunya's (Government of Catalonia) CERCA network, has created the OneChain Immunotherapeutics spin-off, the aim of which is to develop new immuno-oncological therapeutic tools with various preclinical candidates, based on CAR-T technology for different tumors, such as cortical T-cell acute lymphoblastic leukemia (coT-ALL), a rare subtype of leukemia that mainly affects children, and which has a poor prognosis.

20 Jul 2020

How immune cells switch to attack mode

Unraveling a key motif: The T lymphocytes of the immune system work to destroy infected cells or cancer cells. To do so, they have to identify the threat: Molecules perceived as foreign - so-called antigens - bind to the T-cell receptor on the T cell surface.

20 Jul 2020

Behavior therapy that exposes people to traumatic memories does not trigger drug relapse

About a quarter of people with drug or alcohol use disorders also suffer from post-traumatic stress disorder (PTSD), which is typically caused by a traumatic or stressful life event such as rape or combat, and which leaves the person with intense anxiety.

20 Jul 2020

Researchers develop new nano drug that kills triple-negative breast cancer cells

Researchers at the University of Arkansas have developed a new nano drug candidate that kills triple negative breast cancer cells.

20 Jul 2020

Researchers are producing COVID-19 spike proteins to prevent future infections

On July 1, the Texas A&M Engineering Experiment Station's National Center for Therapeutics Manufacturing received funding from the National Institute for Innovation in Manufacturing Biopharmaceuticals to help find a way to prevent the SARS-CoV-2 virus from binding to cells, protecting people from future infections.

19 Jul 2020

Therapy News and Research

Study highlights the impact of gambling on partners and families

Researchers investigate the genetic and molecular basis of PD-L2 regulation

ESC Congress 2020 to host the biggest online gathering of cardiovascular professionals

Researchers identify potential new combination therapy to treat head and neck cancer

Fusion protein may help treat pulmonary arterial hypertension

Research suggests a possible new approach to treating neurodegenerative diseases

Fasting-mimicking diet along with hormone therapy could help treat breast cancer

Mindfulness training helps reduce intimate partner violent behavior in men

Analysis: Mental health crisis will lead to a surge in referrals for NHS’ talking therapy service

Drug discovery pipeline to exploit transcription factors for cancer therapy

Ten major risk factors for Alzheimer's disease

Researchers visualize DNA G-quadruplex formation in live cells for the first time

Age-related hearing loss mainly caused by damage to hair cells, study shows

New assay improves detection of SARS-CoV-2 antibodies

Experimental therapy slows zika replication and prevents microcephaly in mice

Josep Carreras Institute's spin-off aims to develop new immuno-oncological therapeutic tools

How immune cells switch to attack mode

Behavior therapy that exposes people to traumatic memories does not trigger drug relapse

Researchers develop new nano drug that kills triple-negative breast cancer cells

Researchers are producing COVID-19 spike proteins to prevent future infections

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News